Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist - Trial NCT06207851
Access comprehensive clinical trial information for NCT06207851 through Pure Global AI's free database. This phase not specified trial is sponsored by Next Biomedical Co., Ltd. and is currently Recruiting. The study focuses on Osteoarthritis. Target enrollment is 38 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Next Biomedical Co., Ltd.
Timeline & Enrollment
N/A
Jul 13, 2023
Jul 13, 2026
Primary Outcome
Rate of subjects with a 50% or more reduction in QuickDASH Score Change
Summary
In patients with chronic elbow or wrist pain, the pain is controlled by conventional
 conservative therapy The pain reduction effect of Nexsphere-F embolization in patients who
 need additional treatment It is intended to demonstrate safety.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06207851
Device Trial